v3.25.2
GENERAL (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 27, 2025
Jun. 26, 2025
Jan. 16, 2025
Jun. 30, 2025
Feb. 28, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Net loss           $ 5,228,919 $ 4,532,430 $ 4,015,267 $ 3,806,677 $ 9,761,349 $ 7,821,944  
Accumulated deficit       $ 70,200,532   $ 70,200,532       70,200,532   $ 60,439,183
Net cash used in operating activities                   9,065,316 6,414,413  
Proceeds from issuance of equity     $ 2,000,000.0             $ 4,057,719 $ 375,588  
Restatement of shares due to reverse stock split one-for-twenty-eight 1-for-28 reverse stock split                    
Common stock outstanding 604,963 16,946,528   604,963   604,963       604,963   428,799
Convertible Notes Payable [Member]                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Gross proceeds from issuance of convertible notes       $ 5,700,000                
Other offering-related expenses       $ 800,000                
Equity Purchase Agreements [Member]                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Purchase ordinary shares         $ 20,000,000.0              
Standby Equity Purchase Agreement [Member]                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Proceeds from issuance of equity                   $ 1,750,000    
Offering expenses                   $ 100,000